These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24971319)

  • 1. Omics technologies and neovascular ocular disorders.
    Petrovič D; Nguyen QD; Peterlin B; Petrovski G
    Biomed Res Int; 2014; 2014():231348. PubMed ID: 24971319
    [No Abstract]   [Full Text] [Related]  

  • 2. Micro-RNA regulation of the angiogenic response in the diabetic retina.
    Campos-Borges HC; Sanz-González SM; Zanón-Moreno V; Millán Salvador JM; Pinazo-Duran MD
    Arch Soc Esp Oftalmol (Engl Ed); 2020 Jan; 95(1):1-3. PubMed ID: 31629562
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene therapy for diabetic retinopathy: Are we ready to make the leap from bench to bedside?
    Wang JH; Ling D; Tu L; van Wijngaarden P; Dusting GJ; Liu GS
    Pharmacol Ther; 2017 May; 173():1-18. PubMed ID: 28132907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of microRNAs in activating neovascularization pathways in diabetic retinopathy.
    Satari M; Aghadavod E; Mirhosseini N; Asemi Z
    J Cell Biochem; 2019 Jun; 120(6):9514-9521. PubMed ID: 30556195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rapidly developing diabetic retinopathies (nosologic and therapeutic approach)].
    Grange JD; Bensoussan B; Bonnet M
    Bull Soc Ophtalmol Fr; 1983 Nov; 83(11):1341-4. PubMed ID: 6209027
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating microRNA Biomarkers of Diabetic Retinopathy.
    Joglekar MV; Januszewski AS; Jenkins AJ; Hardikar AA
    Diabetes; 2016 Jan; 65(1):22-4. PubMed ID: 26696637
    [No Abstract]   [Full Text] [Related]  

  • 7. Growth factors and diabetic retinopathy.
    Paques M; Massin P; Gaudric A
    Diabetes Metab; 1997 Apr; 23(2):125-30. PubMed ID: 9137900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of functional SNP-1562C>T in MMP9 promoter with proliferative diabetic retinopathy in north Indian type 2 diabetes mellitus patients.
    Singh K; Goyal P; Singh M; Deshmukh S; Upadhyay D; Kant S; Agrawal NK; Gupta SK; Singh K
    J Diabetes Complications; 2017 Dec; 31(12):1648-1651. PubMed ID: 28964682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic retinopathy in two patients with congenital IGF-I deficiency (Laron syndrome).
    Laron Z; Weinberger D
    Eur J Endocrinol; 2004 Jul; 151(1):103-6. PubMed ID: 15248828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of proliferative diabetic retinopathy.
    Gündüz K; Bakri SJ
    Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Haemodynamics and diabetic retinopathy].
    Blum M; Eichhorn M; Vilser W
    Klin Monbl Augenheilkd; 2005 Jun; 222(6):463-70. PubMed ID: 15973624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenic factors in diabetic ocular disease: mechanisms of today, therapies for tomorrow.
    Robinson GS; Aiello LP
    Int Ophthalmol Clin; 1998; 38(2):89-102. PubMed ID: 9604739
    [No Abstract]   [Full Text] [Related]  

  • 13. Angiogenic factors in the development of diabetic iris neovascularization and retinopathy.
    Tolentino MJ; Adamis AP
    Int Ophthalmol Clin; 1998; 38(1):77-94. PubMed ID: 9532473
    [No Abstract]   [Full Text] [Related]  

  • 14. Eye Conditions in Older Adults: Diabetic Retinopathy.
    Kirsch S; Iroku-Malize T
    FP Essent; 2016 Jun; 445():29-37; quiz 38-9. PubMed ID: 27348530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy for the treatment of ocular neovascularization.
    Bradley J; Ju M; Robinson GS
    Angiogenesis; 2007; 10(2):141-8. PubMed ID: 17372853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperglycemia and the pathogenesis of diabetic retinopathy.
    King GL
    J Gen Intern Med; 1986; 1(2):133-4. PubMed ID: 2430081
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipid metabolites in the pathogenesis and treatment of neovascular eye disease.
    Stahl A; Krohne TU; Sapieha P; Chen J; Hellstrom A; Chew E; Holz FG; Smith LE
    Br J Ophthalmol; 2011 Nov; 95(11):1496-501. PubMed ID: 21421650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [When should one use photocoagulation in diabetic retinopathy?].
    Ridings B; Saracco JB; Gastaud P
    Annee Ther Clin Ophtalmol; 1985; 36():83-94. PubMed ID: 2427012
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of small interfering RNA (siRNA) in targeting ocular neovascularization: A review.
    Supe S; Upadhya A; Singh K
    Exp Eye Res; 2021 Jan; 202():108329. PubMed ID: 33198953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiopathology and treatment of diabetic retinopathy].
    Ishibashi T
    Fukuoka Igaku Zasshi; 1995 Oct; 86(10):379-84. PubMed ID: 8529991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.